(Q46354502)

English

Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance

scientific article published on 13 January 2017

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Tumor BRCA1 Reversion Mutation Arising during Neoadjuvant Platinum-Based Chemotherapy in Triple-Negative Breast Cancer Is Associated with Therapy Resistance (English)

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

1 reference

based on heuristic

inferred from title

triple-negative breast cancer

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

object named as

James M Ford

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Allison W. Kurian

5

object named as

Allison W Kurian

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

author name string

Anosheh Afghahi

1

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Kirsten M Timms

2

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Shaveta Vinayak

3

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Kristin C Jensen

4

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Robert W Carlson

6

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Pei-Jen Chang

7

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Elizabeth Schackmann

8

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Anne-Renee Hartman

9

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Melinda L Telli

11

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

language of work or name

0 references

publication date

13 January 2017

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Clinical Cancer Research

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

23

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

13

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

3365-3370

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Phase II Study of Gemcitabine, Carboplatin, and Iniparib As Neoadjuvant Therapy for Triple-Negative and BRCA1/2 Mutation-Associated Breast Cancer With Assessment of a Tumor-Based Measure of Genomic Instability: PrECOG 0105

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Association of BRCA1/2 defects with genomic scores predictive of DNA damage repair deficiency among breast cancer subtypes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Mechanisms of BRCA1 tumor suppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Secondary somatic mutations restoring BRCA1/2 predict chemotherapy resistance in hereditary ovarian carcinomas.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Incidence and outcome of BRCA mutations in unselected patients with triple receptor-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Secondary mutations of BRCA1/2 and drug resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Secondary BRCA1 mutations in BRCA1-mutated ovarian carcinomas with platinum resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Resistance to therapy caused by intragenic deletion in BRCA2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Clinical management of BRCA1 and BRCA2 mutation carriers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

BRCA2 is required for homology-directed repair of chromosomal breaks

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

18 June 2018

A comprehensive laboratory-based program for classification of variants of uncertain significance in hereditary cancer genes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

15 August 2018

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

15 August 2018

Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

3 November 2018

Secondary mutations inBRCA2associated with clinical resistance to a PARP inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5496787

1 December 2018

Loss of heterozygosity in familial tumors from three BRCA1-linked kindreds

1 reference

https://pubmed.ncbi.nlm.nih.gov/28087643

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1158/1078-0432.CCR-16-2174

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

18 June 2018

http://europepmc.org/abstract/PMC/5496787

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46354502&oldid=2208355810"